543 related articles for article (PubMed ID: 3582897)
1. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma.
Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1987 Jul; 93(1):1-11. PubMed ID: 3582897
[TBL] [Abstract][Full Text] [Related]
2. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.
Reid BJ; Blount PL; Rubin CE; Levine DS; Haggitt RC; Rabinovitch PS
Gastroenterology; 1992 Apr; 102(4 Pt 1):1212-9. PubMed ID: 1551528
[TBL] [Abstract][Full Text] [Related]
3. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
[TBL] [Abstract][Full Text] [Related]
4. Barrett's esophagus. Correlation between mucin histochemistry, flow cytometry, and histologic diagnosis for predicting increased cancer risk.
Haggitt RC; Reid BJ; Rabinovitch PS; Rubin CE
Am J Pathol; 1988 Apr; 131(1):53-61. PubMed ID: 3354644
[TBL] [Abstract][Full Text] [Related]
5. Barrett's esophagus, dysplasia, and adenocarcinoma.
Haggitt RC
Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
[TBL] [Abstract][Full Text] [Related]
6. [Flow cytometric analysis of cellular DNA content in Barret's esophagus. A study of 66 cases].
Robaszkiewicz M; Hardy E; Volant A; Nousbaum JB; Cauvin JM; Calament G; Robert FX; Saleun JP; Gouerou H
Gastroenterol Clin Biol; 1991; 15(10):703-10. PubMed ID: 1816011
[TBL] [Abstract][Full Text] [Related]
7. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus.
Geisinger KR; Teot LA; Richter JE
Cancer; 1992 Jan; 69(1):8-16. PubMed ID: 1727677
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions.
Reid BJ; Weinstein WM; Lewin KJ; Haggitt RC; VanDeventer G; DenBesten L; Rubin CE
Gastroenterology; 1988 Jan; 94(1):81-90. PubMed ID: 3335302
[TBL] [Abstract][Full Text] [Related]
9. Barrett's esophagus and esophageal adenocarcinoma.
Reid BJ
Gastroenterol Clin North Am; 1991 Dec; 20(4):817-34. PubMed ID: 1787015
[TBL] [Abstract][Full Text] [Related]
10. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS
Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316
[TBL] [Abstract][Full Text] [Related]
11. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
Lee RG
Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
[TBL] [Abstract][Full Text] [Related]
12. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.
Levine DS; Haggitt RC; Blount PL; Rabinovitch PS; Rusch VW; Reid BJ
Gastroenterology; 1993 Jul; 105(1):40-50. PubMed ID: 8514061
[TBL] [Abstract][Full Text] [Related]
13. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
14. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study.
Cameron AJ; Carpenter HA
Am J Gastroenterol; 1997 Apr; 92(4):586-91. PubMed ID: 9128304
[TBL] [Abstract][Full Text] [Related]
15. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric study using routinely paraffin-embedded tissue.
Giménez A; Minguela A; de Haro LM; Parrilla P; Bermejo J; Pérez D; García AM; Ortiz MA; Molina J; Alvarez R
World J Surg; 2000 Jan; 24(1):72-7. PubMed ID: 10594207
[TBL] [Abstract][Full Text] [Related]
16. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
17. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
Whitson MJ; Falk GW
Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
[TBL] [Abstract][Full Text] [Related]
18. Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
Lomo LC; Blount PL; Sanchez CA; Li X; Galipeau PC; Cowan DS; Ayub K; Rabinovitch PS; Reid BJ; Odze RD
Am J Surg Pathol; 2006 Apr; 30(4):423-35. PubMed ID: 16625087
[TBL] [Abstract][Full Text] [Related]
19. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
20. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
